RIO DE JANEIRO (Reuters) – Brazilian biomedical center Fiocruz will submit a study proposal for researching the use of AstraZeneca’s COVID-19 vaccine in minors, the head of the institute, Nisia Trinidade, said on Tuesday.
Fiocruz has partnered in Brazil with AstraZeneca to finish, distribute and eventually fully produce the vaccine, which is already approved in Brazil for use in adults.
(Reporting by Pedro Fonseca; Editing by Chris Reese)
Man City beats Brighton 4-0 to stay on course for another Premier League title. Phil Foden scores 2
The NFL draft gives players a chance to flaunt their style on the red carpet
QB Jaden Rashada transfers to Georgia after leaving Arizona State
Suns’ Big 3 in a big pickle, down 2-0 against the Timberwolves as series moves to Phoenix
Charlie Woods, son of Tiger, shoots 81 in local qualifier and fails in bid to play in US Open
These people were charged with interfering in the 2020 election. Some are still in politics today
Ukrainian duo heads to the Eurovision Song Contest with a message: We’re still here
Key moments from landmark Supreme Court arguments on Trump’s immunity claims
Appeals court allows Scott Stringer to proceed with defamation case against sex assault accuser who surfaced during previous mayoral run
Prosecutors want a reversal after a Texas woman’s voter fraud conviction was overturned
Minneapolis smokers to pay some of the highest cigarette prices in US with a $15 per-pack minimum
UN report says 282 million people faced acute hunger in 2023, with the worst famine in Gaza
Malaria is still killing people in Kenya, but a vaccine and local drug production may help
US births fell last year, marking an end to the late pandemic rebound, experts say
